Nautilus Biotechnology(NAUT) - 2025 Q4 - Annual Results

Exhibit 99.1 Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results SEATTLE, WA, February 26, 2026 – Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights "In Q4, Nautilus maintained disciplined execution and delivered meaningful progress across our platform develop ...